Seroma control in axillary lymphadenectomy with Glubran 2® without drain. Multicenter, prospective, randomized, clinical trial. GALA-ND study (Glubran, Axillary Lymphadenectomy, Ambulatory, No Drain)
Abstract Background Seroma after breast cancer surgery is a frequent entity; therefore, different products have been described in literature with the aim to reduce it. The most studied ones have been the sealants products, being tested with aspirative drains. Symptomatic seroma represents the 19% af...
Main Authors: | Sandra López Gordo, Neus Ruiz-Edo, Maria Teresa Fernández-Planas, Sara Viscaya-Martín, Cristina Serra-Serra, Breast Cancer Research Group |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-023-07840-w |
Similar Items
-
OK-432 (Sapylin) Reduces Seroma Formation After Axillary Lymphadenectomy in Breast Cancer
by: Deguang Kong, et al.
Published: (2017-01-01) -
Impact of the surgical modality for axillary lymph node dissection on postoperative drainage and seroma formation after total mastectomy
by: Hiroshi Isozaki, et al.
Published: (2019-05-01) -
Effect of One versus Two Drain Insertion on Postoperative Seroma Formation after Modified Radical Mastectomy
by: farzaneh ebrahimifard
Published: (2016-04-01) -
Porcine Dermal Collagen Prevents Seroma Formation After Mastectomy and Axillary Dissection in Rats
by: Cihan Ağalar, et al.
Published: (2017-10-01) -
Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials
by: Maria Luisa Gasparri, et al.
Published: (2021-04-01)